{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "I",
          "alt": "T",
          "position": "1915"
        },
        "variant_string_id": "LRRK2 I1915T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Gain-of-function mutations in leucine-rich repeat kinase 2 (LRRK2) cause familial as well as sporadic Parkinson’s disease (PD) characterized by age-dependent dopaminergic neuron (DN) degeneration.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as age-dependent dopaminergic neuron degeneration caused by gain-of-function mutations in LRRK2."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "We generated an in vivo EGFP reporter with let-7-binding sites in the 3′UTR (EGFP-let-7-3′UTR). Da-Gal4-directed ubiquitous or TH-Gal4-directed DN-specific co-expression of pathogenic dLRRK(I1915T) or hLRRK2(G2019S) all stimulated reporter expression, more so than WT proteins.",
          "judgment": "Yes",
          "reasoning": "The assay used effectively models the disease pathogenesis/mechanism as it involves the interaction of LRRK2 with the miRNA pathway, which is relevant to the regulation of protein synthesis and neuronal function.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "judgment": "Yes",
          "reasoning": "The paper describes the use of both wild-type and pathogenic variants of LRRK2 in the assay, providing a direct comparison and control. The effect of the variants on reporter expression is quantified and statistically significant, indicating a valid assay."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "sub_step_name": "4a: Statistical Analyses",
          "extracted_paper_info": "Values represent EGFP levels in the transgenic crosses relative to the control from three independent experiments (*P<0.05, n=3).",
          "judgment": "Yes",
          "reasoning": "The paper provides statistical evidence with p-values and sample sizes, indicating that the functional assay results are significant and can be used to estimate the OddsPath for the variant.",
          "next_step_or_outcome": "Proceed to Step 4c"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "sub_step_name": "4c: Correlate OddsPath",
          "extracted_paper_info": "Da-Gal4-directed ubiquitous or TH-Gal4-directed DN-specific co-expression of pathogenic dLRRK(I1915T) or hLRRK2(G2019S) all stimulated reporter expression, more so than WT proteins.",
          "judgment": "Yes",
          "reasoning": "The functional assay results show a clear difference in reporter expression between the pathogenic variant and wild-type proteins, suggesting a gain-of-function effect that can be used to infer the OddsPath.",
          "next_step_or_outcome": "PS3_very_strong"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The functional evidence for LRRK2 I1915T variant is very strong, indicating a pathogenic effect, based on the significant stimulation of reporter expression in the assay system compared to wild-type proteins, and the statistical significance of the results."
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "G",
          "alt": "S",
          "position": "2019"
        },
        "variant_string_id": "LRRK2 G2019S"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Gain-of-function mutations in leucine-rich repeat kinase 2 (LRRK2) cause familial as well as sporadic Parkinson’s disease (PD) characterized by age-dependent dopaminergic neuron (DN) degeneration.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as age-dependent dopaminergic neuron degeneration caused by gain-of-function mutations in LRRK2."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "We generated an in vivo EGFP reporter with let-7-binding sites in the 3′UTR (EGFP-let-7-3′UTR). Da-Gal4-directed ubiquitous or TH-Gal4-directed DN-specific co-expression of pathogenic dLRRK(I1915T) or hLRRK2(G2019S) all stimulated reporter expression, more so than WT proteins.",
          "judgment": "Yes",
          "reasoning": "The assay used effectively models the disease pathogenesis/mechanism as it involves the interaction of LRRK2 with the miRNA pathway, which is relevant to the regulation of protein synthesis and neuronal function.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "judgment": "Yes",
          "reasoning": "The paper describes the use of both wild-type and pathogenic variants of LRRK2 in the assay, providing a direct comparison and control. The effect of the variants on reporter expression is quantified and statistically significant, indicating a valid assay."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "sub_step_name": "4a: Statistical Analyses",
          "extracted_paper_info": "Values represent EGFP levels in the transgenic crosses relative to the control from three independent experiments (*P<0.05, n=3).",
          "judgment": "Yes",
          "reasoning": "The paper provides statistical evidence with p-values and sample sizes, indicating that the functional assay results are significant and can be used to estimate the OddsPath for the variant.",
          "next_step_or_outcome": "Proceed to Step 4c"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "sub_step_name": "4c: Correlate OddsPath",
          "extracted_paper_info": "Da-Gal4-directed ubiquitous or TH-Gal4-directed DN-specific co-expression of pathogenic dLRRK(I1915T) or hLRRK2(G2019S) all stimulated reporter expression, more so than WT proteins.",
          "judgment": "Yes",
          "reasoning": "The functional assay results show a clear difference in reporter expression between the pathogenic variant and wild-type proteins, suggesting a gain-of-function effect that can be used to infer the OddsPath.",
          "next_step_or_outcome": "PS3_very_strong"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The functional evidence for LRRK2 G2019S variant is very strong, indicating a pathogenic effect, based on the significant stimulation of reporter expression in the assay system compared to wild-type proteins, and the statistical significance of the results."
    }
  ]
}